top of page


Asieris and Theramex sign licensing agreement for cervical precancer therapy Cevira
Asieris and Theramex have entered a licensing agreement for Cevira, a treatment platform targeting cervical precancerous lesions.

nuaxia
Oct 82 min read


Orion Pharma and Qilu partner on pembrolizumab biosimilar for Europe
Orion Pharma and Qilu Pharma Europe have entered a European commercialisation agreement for a proposed intravenous pembrolizumab biosimilar.

nuaxia
Oct 72 min read


Medovate and JEB Technologies combine into single medical-device company
Medovate and JEB Technologies are combining into a single medical-device company under the Medovate name, integrating product development, manufacturing, regulatory and commercial capabilities.

nuaxia
Sep 172 min read
bottom of page